Anti-tumor necrosis factor-α activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine lyme borreliosis: An unproven conclusion

Journal of Infectious Diseases

Volumn 196, Issue 12, 2007, Pages 1865-1866

  Wormser, Gary P ^a   Barthold, Stephen W ^b   Shapiro, Eugene D ^c   Dattwyler, Raymond J ^a   Bakken, Johan S ^e   Steere, Allen C ^f   Bockenstedt, Linda K ^c   Radolf, Justin D ^d  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e St Luke's Hospital   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; DOXYCYCLINE; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; BORRELIA BURGDORFERI; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; HUMAN; LETTER; LYME DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPIROCHETE; SYNOVECTOMY; TREATMENT DURATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; MICROBIOLOGY; MOUSE; NOTE; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; BORRELIA BURGDORFERI; CEFTRIAXONE; HUMANS; LYME DISEASE; MICE; SPIROCHAETALES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39149136202     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/523826     Document Type: Letter

References (6)

1. Yrjänäinen H, Hytonen J, Song XY, Oksi J, Hartiala K, Viljanen MK. Anti-tumor necrosis factor-α treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice. J Infect Dis 2007; 195: 1489-96.
2. Malawista SE, Barthold SW, Persing DH. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J Infect Dis 1994; 170:1312-6.
3. Luft BJ, Volkman DJ, Halperin JJ, Dattwyler RJ. New chemotherapeutic approaches in the treatment of Lyme borreliosis. Ann NY Acad Sci 1988; 539:352-61.
4. Moody KD, Adams RL, Barthold SW. Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice. Antimicrob Agents Chemother 1994; 38:1567-72.
5. Wang E, Bergeron Y, Bergeron MG. Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia. J Antimicrob Chemother 2005; 55:721-6.
6. Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 2006; 54: 3079-85.